Anti-SYCP2 monoclonal antibody

Pre-made anti-SYCP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYCP2/SYCP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2762-Ab-1/ GM-Tg-hg-IP2762-Ab-2Anti-Human SYCP2 monoclonal antibodyHuman
GM-Tg-rg-IP2762-Ab-1/ GM-Tg-rg-IP2762-Ab-2Anti-Rat SYCP2 monoclonal antibodyRat
GM-Tg-mg-IP2762-Ab-1/ GM-Tg-mg-IP2762-Ab-2Anti-Mouse SYCP2 monoclonal antibodyMouse
GM-Tg-cynog-IP2762-Ab-1/ GM-Tg-cynog-IP2762-Ab-2Anti-Cynomolgus/ Rhesus macaque SYCP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2762-Ab-1/ GM-Tg-felg-IP2762-Ab-2Anti-Feline SYCP2 monoclonal antibodyFeline
GM-Tg-cang-IP2762-Ab-1/ GM-Tg-cang-IP2762-Ab-2Anti-Canine SYCP2 monoclonal antibodyCanine
GM-Tg-bovg-IP2762-Ab-1/ GM-Tg-bovg-IP2762-Ab-2Anti-Bovine SYCP2 monoclonal antibodyBovine
GM-Tg-equg-IP2762-Ab-1/ GM-Tg-equg-IP2762-Ab-2Anti-Equine SYCP2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2762-Ab-1/ GM-Tg-hg-IP2762-Ab-2; GM-Tg-rg-IP2762-Ab-1/ GM-Tg-rg-IP2762-Ab-2;
GM-Tg-mg-IP2762-Ab-1/ GM-Tg-mg-IP2762-Ab-2; GM-Tg-cynog-IP2762-Ab-1/ GM-Tg-cynog-IP2762-Ab-2;
GM-Tg-felg-IP2762-Ab-1/ GM-Tg-felg-IP2762-Ab-2; GM-Tg-cang-IP2762-Ab-1/ GM-Tg-cang-IP2762-Ab-2;
GM-Tg-bovg-IP2762-Ab-1/ GM-Tg-bovg-IP2762-Ab-2; GM-Tg-equg-IP2762-Ab-1/ GM-Tg-equg-IP2762-Ab-2
Products NameAnti-SYCP2 monoclonal antibody
Formatmab
Target NameSYCP2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYCP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2762-Ag-1Recombinant multi-species SYCP2/ SCP-2/ SCP2 protein


    Target information

    Target IDGM-IP2762
    Target NameSYCP2
    Gene ID10388,320558,83820,100423232,477278,101086965,784000,100051057
    Gene Symbol and Synonyms3830402K23Rik,4930518F03Rik,SCP-2,SCP2,SPGF1,SYCP2
    Uniprot AccessionQ9BX26,O70608
    Uniprot Entry NameSYCP2_HUMAN,SYCP2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196074
    Target ClassificationN/A

    The target: SYCP2, gene name: SYCP2, also named as SCP-2, SCP2. The synaptonemal complex is a proteinaceous structure that links homologous chromosomes during the prophase of meiosis. The protein encoded by this gene is a major component of the synaptonemal complex and may bind DNA at scaffold attachment regions. The encoded protein requires synaptonemal complex protein 3, but not 1, for inclusion in the synaptonemal complex. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.